Ob/Gyn Medical News about Influenza A Virus, H1N1 Subtype Vaccines

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Pregnant Women. No Safety Concerns Reported During Ongoing Clinical Trial
American Family Physician, 11/06/09

According to a Nov. 2 NIH news release, the H1N1 flu vaccine elicited an immune response likely to be protective in 92 percent of pregnant women who received a single 15–microgram dose. The immune response increased to 96 percent in a group of pregnant women that received a single 30–microgram dose. The immune response seen in healthy pregnant women is comparable to that seen in nonpregnant healthy adults. According to the CDC, at least 100 pregnant women have been hospitalized in U.S. intensive care units since the H1N1 outbreak started in the spring. The deaths of 28 pregnant women have been linked to the virus. Participants in the trial ranged in age from 18–39 years and began the study while in their second or third trimester. The NIAID said no safety concerns related to the vaccine – which does not include the preservative thimerosal or any adjuvant – have arisen.

<< Previous
Management of prenatally diagnosed congenital diaphragmatic...

Next >>
Augmentation Mammaplasty by Reverse Abdominoplasty (AMBRA)

H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09 Relevance Score: 97%

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09 Relevance Score: 97%

Update on 2009 pandemic influenza A (H1N1) virus
Cleveland Clinic Journal of Medicine, 10/05/09 Relevance Score: 97%

H1N1 vaccine shortage leaves doctors managing crowds, anxieties
American Medical News, 11/06/09 Relevance Score: 96%

H1N1 Vaccine Production, Availability Increasing Slowly
American Family Physician, 11/02/09 Relevance Score: 96%